Astellas, Cytokinetics collaborate in skeletal muscle activators; deal amended
In a two-year collaboration, Astellas Pharma Inc. and Cytokinetics Inc. will jointly research skeletal muscle activation to identify, characterize, and optimize drug candidates for muscle diseases.
- Includes Contract
- Includes Equity
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com